Authors
Loading...
Preclinical study reveals that IL-17 deficiency dramatically reduces skin tumor development in mice, indicating the IL-17-Stat3 pathway promotes cancer-associated inflammation.
Wang et al. (2010) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: